Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Short-term Investments (2019 - 2025)

Outset Medical (OM) has disclosed Short-term Investments for 7 consecutive years, with $133.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 286.32% to $133.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $133.9 million, a 286.32% increase, with the full-year FY2025 number at $133.9 million, up 286.32% from a year prior.
  • Short-term Investments was $133.9 million for Q4 2025 at Outset Medical, down from $142.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $214.3 million in Q4 2022 to a low of $25.7 million in Q1 2021.
  • A 5-year average of $142.0 million and a median of $142.4 million in 2021 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: skyrocketed 689.73% in 2021, then crashed 74.28% in 2024.
  • Outset Medical's Short-term Investments stood at $157.1 million in 2021, then skyrocketed by 36.36% to $214.3 million in 2022, then plummeted by 37.08% to $134.8 million in 2023, then plummeted by 74.28% to $34.7 million in 2024, then surged by 286.32% to $133.9 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Short-term Investments are $133.9 million (Q4 2025), $142.2 million (Q3 2025), and $113.1 million (Q1 2025).